Blocking PCBP2 Condensates Eases Alzheimer’s Symptoms
In a groundbreaking advance that could redefine therapeutic approaches to neurodegenerative diseases, researchers have unveiled a novel pharmacological strategy targeting PCBP2 biomolecular condensates, offering renewed...















